by Sandeep Gupta | May 15, 2019 | Cancer (solid tumor), Publication
Abstract Authors: Kariburyo F, Wang Y, Cheng IN, Wang L, Morgenstern D, Asner I, Xie L, Meadows E, Danella J. Objective: This study explored short-term healthcare costs of men managed with observation strategies (OBS) vs immediate treatment (IMT) for favorable...
by Sandeep Gupta | May 15, 2019 | Cancer (blood), Cancer (solid tumor), Publication
Abstract Authors: Wang L, Baser O, Kutikova L, Page JH, Barron R Purpose: The study aims to assess the relative efficacy of granulocyte colony-stimulating factor (G-CSF) products administered as primary prophylaxis (PP) to patients with cancer receiving...
by Sandeep Gupta | May 13, 2019 | Cancer (solid tumor), Publication
Abstract Authors: Bui CN, Wang L, Baser O. Objectives: Corticosteroids (CSs) are used concomitantly with life-extending therapies (LETs) in patients with castration-resistant prostate cancer (CRPC). This study examined time to LETs, LETs and concomitant CS...
by Sandeep Gupta | May 12, 2019 | Cancer (blood), Cancer (solid tumor), Publication
Abstract Authors: Wang L, Barron R, Baser O, Langeberg WJ, Dale DC Background: The Veterans Health Administration (VHA) is the largest integrated health care system in the United States and a major cancer care provider. Objective: To use VHA database to conduct a...
by Sandeep Gupta | May 10, 2019 | Cancer (solid tumor), Publication
Abstract Authors: Baser O, Wei W, Henk HJ, Teitelbaum A, Xie L. Objective: Triple-negative breast cancer (TNBC) is a high-grade breast cancer with an aggressive clinical course. We examined the recurrence rate, health care utilization, and cost of early-stage TNBC in...
by Sandeep Gupta | May 8, 2019 | Cancer (solid tumor), Publication
Abstract Authors: Baser O, Wei W, Henk HJ, Teitelbaum A, Xie L. Background: Triple-negative breast cancer (TNBC) makes up 10-17% of all breast cancers and, due to lack of receptor expression, is unresponsive to therapies that target hormonal receptors or HER2....
